Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Principal Scientist
Watson Pharmaceuticals - Fort Lauderdale, FL
Patient Support Specialist Job
Celgene Corporation - Berkeley Heights, NJ, US
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US
Hematology Oncology Consultant, Hematology - Louisiana North Job
Celgene Corporation - Louisiana, LA, US
Partner
Lundbeckfond Ventures - Copenhagen, Denmark

More Jobs >>

Events

Biomarker Applications for Improved Clinical Trial Outcomes
Nov. 15-16 — Boston
CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami
New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA

More Events >>

Related Tags >> venture capital Malaria PATH Malaria Vaccine Initiative Bill & Melinda Gates Foundation

Liquidia Technologies News

Most Popular Liquidia Technologies Story

Gates steps in to vaccine VC with $10M investment

March 9, 2011 — 2:21pm ET | By Maureen Martino

The Bill and Melinda Gates Foundation, long a staunch supporter of vaccines for children, is putting its money where its mouth is with a $10 million investment in Liquidia Technologies. Xconomy notes Read more...

Liquidia Technologies Press Releases

Liquidia Technologies Receives Investment Deal of the Year Award from Southeast BIO
Liquidia Founder and CEO Named Ernst & Young Entrepreneur of the Year® 2011 Finalists
Liquidia Technologies Receives Significant Equity Investment to Bolster Development of Next Generation Vaccines
Liquidia Technologies Receives Significant Equity Investment to Bolster Development of Next Generation Vaccines
Liquidia Technologies Announces Collaboration with the Path Malaria Vaccine Initiative

Latest Headlines

With Gates Foundation backing, Liquidia advances novel flu vaccine
July 13, 2011
Gates steps in to vaccine VC with $10M investment
March 9, 2011
PATH to use Liquidia particle technology for malaria
February 9, 2011
Liquidia closes $25M Series C to fund vaccine delivery tech
April 22, 2010

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK